Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 9, 1998

View Archived Issues

Company Profile: PolyMASC

CNS-5161 shows efficacy in phase I trial

Barr receives additional generic approval

Cell Therapeutics and City of Hope join forces for diabetes research

Second-generation CMV retinitis compound enters phase I/II

Beaufour Ipsen to market Tanabe ACE inhibitor

Serotone introduced in China

Ares-Serono's recombinant IFN-beta1a recommended for approval by CPMP for MS

MycoTox's antifungal program advances

New rationale elucidated for clinical evaluation of GW-506U in refractory hematologic malignancies

ADCON-L submitted to regulatory authorities

Report of ThromboSol efficacy presented at hematology congress

Genetronics' electroporation therapy further evaluated in French trial

Genentech licenses TPO to Pharmacia & Upjohn

Thrombin inhibitors reported by BMS

Novel diagnostic compositions reported by Amersham

New antiviral agents emerge from European research collaboration

HCAP discovered by Incyte; potential treatment for obesity

New therapeutic protein reported by Amgen

New phosphatase inhibitors from the University of Pittsburgh

Merck discloses novel D4 receptor ligands

Epix Medical's MRI contrast agent evaluated for breast cancer indications

NIH announces contemplation of licensing agreement for growth factors

NIH communication reports contemplation of licensing agreement

NIH seeks CRADA partners or licensees for 12-LO metabolite

New antiulcer agent now available in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...